Sexually transmitted disease

Government launches ‘ambitious’ asymptomatic mpox transmission study

Results of the PRIME study will be used to inform the public health outbreak response to mpox, including future vaccination and testing strategies.…

Chlamydia: screening, diagnosis and management

Chlamydia is the most common sexually transmitted infection in the UK. Learn the signs and symptoms of chlamydia, who is eligible for screening and how to treat it.…

Chlamydia screening in pharmacies decreases by 7% in 2019 as STI rates rise

Chlamydia testing in community pharmacies fell by 7% in 2019, despite a 2% overall increase in tests carried out through the National Chlamydia Screening Programme during the year.…

Gonorrhoea infection: diagnosis and treatment

Diagnoses of gonorrhoea in England rose by 26% between 2018 and 2019. Pharmacy teams can help prevent transmission and promote good sexual health practices through identifying patients at risk.…

Community pharmacy pilots ‘safe haven’ for those who have experienced sexual abuse

A community pharmacy in east London has begun a pilot to provide a refuge for people who have experienced sexual abuse following a spike in cases during the COVID-19 pandemic.…

Stopping the spread: ending the resurgence of gonorrhoea

Incidence of sexually transmitted infections is increasing and antimicrobial resistance is adding fuel to the fire, particularly in the case of gonorrhoea. In response, researchers are working on three major strategies to help reduce its spread and maintain susceptibility to antibiotics.…

How pharmacy is helping to contain the resurgence of gonorrhoea and syphilis

As the prevalence of sexually transmitted infections continues to rise and sexual health services remain under financial strain, pharmacists are increasingly being called upon to do more to bridge the gap.…

Antibiotic treatment of Mycoplasma genitalium infection

An overview of the 2018 guideline for management of this sexually transmitted infection in men and women.…

Boys aged 12 and 13 years to be offered HPV vaccine from September 2019, PHE announces

From September 2019, boys aged 12 and 13 years will be offered the free human papillomavirus vaccine, Public Health England has announced.…

Gentamicin not appropriate as first-line treatment for gonorrhoea, researchers say

Gentamicin is no more effective overall than ceftriaxone as a first-line treatment for gonorrhoea but could be a useful alternative for some patients, researchers have said.…